Pfizer unveiled a multi-drug R&D collaboration with Innovent Biologics, making it the latest big pharma company to reach a deal that taps into Chinese labs to source biotech innovation. This alliance will focus on developing next-generation drugs in the class of targeted cancer therapies called antibody drug conjugates. The post Pfizer’s $10.5B Deal With One…
Garner’s Series E round was led by Index Ventures with participation from Kleiner Perkins, Redpoint, Thrive, Sequoia, Founders Fund and Kaiser Permanente Ventures. The post Garner Health Secures $100M to Connect Patients with High-Performing Doctors appeared first on MedCity News.
The next evolution in digital health is layering intelligent orchestration on top of the EHR to activate care in real time. It’s a platform plus orchestration layer, powered by AI and designed for action. The post The EHR Was Built to Store Data — It Wasn’t Built to Orchestrate Care appeared first on MedCity News.
When every metric is treated as important, nothing actually stands out. Leaders spend more time interpreting data than acting on it. And in a system as complex as healthcare, delays in decision-making can have real operational and financial consequences. The post The Illusion of Visibility: Why More Data Doesn’t Mean Better Decisions appeared first on…
For most of human history, cellular aging was treated as biologically fixed, an inevitable accumulation of damage with no meaningful pathway to reversal. That assumption is no longer tenable. The post Aging is Soon to Be a Preventable Disease appeared first on MedCity News.
Through a new partnership, Teladoc Health’s virtual services are now available on Walmart’s Better Care Services platform. The post Walmart, Teladoc Team Up to Expand Access to Virtual Care appeared first on MedCity News.
CMS finalized a new rule aimed at streamlining the No Surprises Act’s overwhelmed arbitration system. Provider groups largely welcomed the reforms — though some industry leaders said additional changes are still needed to address alleged misuse and improve transparency. The post CMS Finalizes Rule to Simplify Payer-Provider Disputes Under No Surprises Act appeared first on…
AbbVie drug Decnupaz received FDA approval for treating blastic plasmacytoid dendritic cell neoplasm, or BPDCN. This antibody drug conjugate came from AbbVie’s 2023 ImmunoGen acquisition. The post AbbVie’s ADC Strategy Notches Another Win With FDA Approval in Ultra-Rare Blood Cancer appeared first on MedCity News.
[Sponsored] In this episode, we’re joined by Janna Manjelievskaia, director of health economics and outcomes research at Veradigm. We discuss Veradigm’s recent Women’s Health Insights Report, which highlights the complicated history around Hormone Replacement Therapy (HRT), a medication used to treat menopause. The post MedCity FemFwd: The Complicated History Behind Hormone Replacement Therapy appeared first…
AI doesn’t just demand better processes. It requires a complete redesign of traditional healthcare operations for a new level of precision, traceability, and governance. A new operating model that the vast majority of healthcare organizations simply aren’t built around today. The post Healthcare AI Is Only As Good As the Systems That Govern It appeared…